Rajiv Amin
Keine laufenden Positionen mehr
Vermögen: - $ am 31.03.2024
Profil
Rajiv Amin worked as a Senior Director of Financial Reporting at Alvogen, Inc. and Kyowa Kirin, Inc. He also worked as a Controller-Americas at Convatec Group Plc.
Amin received his undergraduate degree from the University of Scranton and his graduate degree from Babson College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.03.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Ehemalige bekannte Positionen von Rajiv Amin
| Unternehmen | Position | Ende |
|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Corporate Officer/Principal | - |
| Kyowa Kirin, Inc. | Corporate Officer/Principal | - |
| CONVATEC GROUP PLC | Corporate Officer/Principal | - |
| IPI LEGACY LIQUIDATION CO | Finanzdirektor/CFO | 10.05.2023 |
Ausbildung von Rajiv Amin
| Babson College | Graduate Degree |
| University of Scranton | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IPI LEGACY LIQUIDATION CO | Health Technology |
| CONVATEC GROUP PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Kyowa Kirin, Inc. | |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
